Biotech · Private company
Nanoscope Therapeutics Inc.
Track this companyFree. Adds Nanoscope Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Gene Therapy Product-MCO-010Phase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Gene Therapy-vMCO-010Phase 2 · Stargardt DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sham InjectionPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- Gene Therapy Product-MCO-010Stargardt DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ObservationalMacular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- ObservationalRetinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTRECRUITING · started Jan 28, 2025ClinicalTrials.gov NCT06805474 · fetched Nov 12, 2026
- Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE StudyACTIVE_NOT_RECRUITING · started Dec 8, 2023ClinicalTrials.gov NCT06162585 · fetched Nov 12, 2026
- Non-interventional Long Term Follow-up Study of Participants Previously Enrolled in the STARLIGHT StudyACTIVE_NOT_RECRUITING · started Oct 19, 2023ClinicalTrials.gov NCT06048185 · fetched Nov 12, 2026
- Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTCOMPLETED · started Apr 25, 2023ClinicalTrials.gov NCT05820100 · fetched Nov 12, 2026
- Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt DiseasePHASE2 · COMPLETED · started Jul 5, 2022ClinicalTrials.gov NCT05417126 · fetched Nov 12, 2026
- Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]PHASE2 · COMPLETED · started Jul 13, 2021ClinicalTrials.gov NCT04945772 · fetched Nov 12, 2026